Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Viral Mutations, Lineages, And Strains – Expert Reaction

A pre-print study says there is a new, quickly spreading mutation of the SARS-CoV-2 virus.

The study – which has not been peer reviewed – also suggests the mutations could affect vaccine or treatment development.

The SMC asked experts to comment on the pre-print study.

David Welch, Senior Lecturer, Centre of Computational Evolution and School of Computer Science, University of Auckland, comments:

“Mutations occur in all viruses. Most mutations do not change the epidemiology of the virus, that is, they don’t change things like how easily it is transmitted or how sick it makes people. Viruses that are the same, except for a few mutations, are often called different lineages. When a mutation arises that does materially change the viral epidemiology, we call it a new strain.

“No new strains of SARS-CoV-2 have yet been identified. But plenty of mutations have occurred and many different lineages are circulating. A recent article (that is not yet peer-reviewed) claims a new strain has arisen, based on a mutation (change from ‘G’ to an ‘A’) in a region coding for a protein important to the way the virus attaches to human cells. This is mainly based on observing that the proportion of viruses with this mutation has increased over time. They show that there is no difference in clinical outcomes for this lineage.

“Many factors could have caused the increased frequency of this mutation and it is very hard to separate them out. The biggest driver of the differing prevalence of viral lineages in different locations is chance. Most countries have seen multiple introductions (New Zealand, for example, had over 500). Chance dictates which of these lineages takes hold and becomes an important part of an outbreak in any location. The authors attempt to separate out these effects but have inadequate evidence to say anything conclusive.

“If the ‘strain’ in question were substantially more transmissible than others, it would rapidly become very obvious due to the nature of exponential growth – if two things are growing exponentially but at substantially different rates, the one with a higher rate will grow much more quickly than the one with the lower rate. This has not happened so any difference in transmissibility, if it exists, must be small.”

No conflict of interest.

Dr Jemma Geoghegan, Virologist, Senior Lecturer, University of Otago, comments:

“When a virus replicates it often makes mistakes, or mutations. Most mutations are neutral and have no or little effect on the function of a virus, or alter its transmissibility or the severity of the disease it causes. Sometimes, however, mutations can influence the way a virus infects its host.

“There are hundreds of mutations that have been detected in the genomes of SARS-CoV-2. One mutation that people are paying close attention to is called D614G, which is a mutation in the spike protein (the amino acid D changed to a G at position 614). It has been suggested that this mutation has led to an increase in the virus’ transmissibility.

“The problem with drawing this conclusion is that this mutation first occurred in the founding virus types in Europe. It is likely, then, that this variant of the virus with a G amino acid just got lucky and due to the ‘founder effect’ it increased in frequency – i.e., the virus got there first and so started spreading first. The virus variant with a D amino acid remains more frequent in Asia, where the virus first broke out. Countries like New Zealand have about a 50:50 mix of each type – that’s because we have had many incursions of the virus from different parts of the world.

“It is not yet possible to say whether the mutation has caused an increase in transmissibility. To make such a conclusion, researchers would need to conduct experiments using cell culture and/or animal models in the lab.

“As for a vaccine, it is important to monitor any changes in the virus’ genome that are increasing in frequency. The spike protein is particularly important for any potential therapeutics, so it is worth monitoring mutations in this region carefully.”

No conflict of interest.

Dr Matloob Husain, Senior Lecturer in Virology, Department of Microbiology and Immunology, University of Otago, comments:

“Just like influenza, SARS 2.0 is one of the RNA viruses which are notorious for evolution in the host. When a RNA virus is novel (like SARS 2.0) and the population is naïve (doesn’t have pre-existing immunity), it spreads fast among the population (this is what happening in SARS 2.0 case). During its spread, a virus may mutate to adapt better in the population. Basically, this is what the paper in question is informing.

“They have identified particularly one prevalent mutation (D614G) in the spike protein which would be the target of many vaccines under development; this mutation could be detrimental to the efficacy of those vaccines. However, with the methods they have used, it is difficult to conclude that the circulating virus with this mutation is more contagious/pathogenic.

“Constant evolution is the main reason behind recurring seasonal influenza epidemics and need for flu vaccination every year; we may see the same with SARS 2.0 if it keeps circulating and evolving.”

No conflict of interest.
 

Associate Professor James Ussher, Department of Microbiology and Immunology, University of Otago, comments:
 

“This is an interesting paper. It seems that the D614G mutation in the spike protein is becoming more frequent over time and is spreading geographically. It does not seem to be associated with more severe disease but may be associated with increased transmission. The effects on transmission, however, will need to be confirmed in experiments in the laboratory (in vitro cell culture and animal models).

“It is uncertain at this time what impact this might have on vaccine development. The mutation is in an area of the spike protein that has previously been shown to be a target of antibody responses. However, it is not in the area of the spike protein that is involved with binding to its receptor (the receptor binding domain), ACE2. Most vaccine strategies are targeting the spike protein, trying to induce antibodies that bind to the receptor binding domain, preventing viral entry. This paper identified very few mutations to date in the receptor binding domain, which is encouraging for vaccine design. Laboratory experiments are required to define the impact, if any, of the D614G mutation on immune escape.”
 

No conflict of interest.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Maritime NZ: NZ Joins Global Initiative Keeping Ports Open And Freight Moving

New Zealand has joined an international port authorities’ global initiative for safe and efficient movement of goods and shipping during the COVID-19 crisis. World-wide, 56 port authorities have agreed how they will work together facilitating maritime ... More>>

ALSO:

National: National Backs Businesses With $10k JobStart

National will provide a $10,000 cash payment to businesses that hire additional staff as part of our commitment to keeping New Zealanders in jobs, National Party Leader Todd Muller and Finance spokesperson Paul Goldsmith have announced. Our JobStart ... More>>

ALSO:

DIY Law: Government Exempts Some Home Improvements From Costly Consents

Homeowners, builders and DIYers will soon have an easier time making basic home improvements as the Government scraps the need for consents for low-risk building work such as sleep-outs, sheds and carports – allowing the construction sector ... More>>

ALSO:

Media Awards: The New Zealand Herald Named Newspaper Of The Year, Website Of The Year At Voyager Media Awards

The New Zealand Herald has been labelled a “powerhouse news operation” as it claims the two biggest prizes – Newspaper of the Year and Website of the Year – along with many individual awards at the 2020 Voyager Media Awards Website of the ... More>>

ALSO:

ASB Bank: ASB Takes The Lead Again With New Low Home Loan Interest Rate

ASB has moved again to support its customers, cutting a number of home loan rates, including the two-year special rate to a new low of 2.69% p.a. Craig Sims, ASB executive general manager Retail Banking says the reduced rate will be welcome news for many ... More>>

ALSO:

Nathan Hoturoa Gray: The Problems With Testing And Case Statistics For Covid-19

To begin to understand disease transmission in a country requires adequate testing of your population with properly vetted, accurate tests. As the world struggles to find what 'adequate percentage' of the population is necessary, (estimates predict ... More>>

ALSO:

RNZ: Fletcher Building To Lay Off 1000 Staff In New Zealand

The construction company will cut around 10 percent of its workforce as it struggles with the fallout from Covid-19. More>>

ALSO:

Can Pay, Won't Pay: Cashflow Moves Urged

Government Ministers are asking significant private enterprises to adopt prompt payment practices in line with the state sector, as a way to improve cashflow for small businesses. More>>

ALSO:

Gordon Campbell: On Why We Should Legally Protect The Right To Work From Home

For understandable reasons, the media messaging around Level Two has been all about “freedom” and “celebration”, but this is not necessarily going to be a universal experience. When it comes to workplace relations, Level Two is just as likely to ... More>>

ALSO:



Auckland Airport: Thousands Of Kiwis Travelling For Queen’s Birthday Weekend


Confidence in domestic travel is beginning to steadily ramp up, with thousands of Kiwis travelling within New Zealand for Queen’s Birthday.
Nearly 400 flights will be operating to and from Auckland Airport over the long weekend... More>>

ALSO:

Science Media Centre: Understanding 5G Concerns – Expert Q&A


Recent attacks on cell phone towers have brought concerns over the rollout of 5G technology into sharp relief.
While scientific research has consistently shown that the technology does not adversely affect human health, public concerns about its impact have spread around the world, fueled in part by growing misinformation online. The SMC asked experts to comment... More>>

ALSO:


Trade: Record Monthly Surplus As Imports Dive

Imports in April 2020 had their biggest fall since October 2009, resulting in a monthly trade surplus of $1.3 billion, Stats NZ said today. “This is the largest monthly trade surplus on record and the annual goods trade deficit is the lowest ... More>>

ALSO:


Media Blues: Stuff Chief Executive Buys Company For $1

Stuff chief executive Sinead Boucher has purchased Stuff from its Australian owners Nine Entertainment for $1.
The chief executive was returning the company to New Zealand ownership, with the sale is expected to be completed by 31 May.
"Our plan is to transition the ownership of Stuff to give staff a direct stake in the business as shareholders," Boucher said in a statement.... More>>

ALSO:

RNZ: Bar Reopening Night 'much, Much Quieter'

Pubs and bars are reporting a sluggish first day back after the lockdown, with the fear of going out, or perhaps the joy of staying home, thought to be a reason for the low numbers. More>>

ALSO:

Stats NZ: New Zealand’s Population Passes 5 Million

New Zealand's resident population provisionally reached 5 million in March 2020, Stats NZ said today. More>>

NIWA: Seven Weeks Of Clearing The Air Provides Huge Benefits: Scientist

Seven weeks of lockdown has provided evidence of how pollution can vanish overnight with benefits for the environment and individuals, says NIWA air quality scientist Dr Ian Longley. Dr Longley has been monitoring air quality in Auckland, Wellington ... More>>

ALSO:

Government: Milestone In Cash Flow Support To SMEs

A significant package of tax reforms will be pushed through all stages in Parliament today to throw a cash flow lifeline to small businesses. More>>

ALSO: